Sudeep Pharma IPO

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium  The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients. Product Portfolio: Pharmaceutical, Food and Nutrition Business Specialty Ingredients Business Triturates As of December 31, 2024, the company had 704 permanent employees. Competitve Strengths: Market leadership with a diversified product portfolio in a high barrier industry Distinguished global customer base with long-standing relationships with key customers Well-equipped and regulatory compliant Manufacturing Facilities Strong research and development capabilities

The Company Sudeep Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (₹ in crores) 1 Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I 75.81 2 General corporate purposes 12.67

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App